Edwards Lifesciences Corporation
MX ˙ BMV ˙ US28176E1082
SecurityMX:EW / Edwards Lifesciences Corporation
InstitutionGranite Harbor Advisors, Inc.
Latest Disclosed Ownership4,517 shares
Latest Disclosed Value $ 361,721
Granite Harbor Advisors, Inc. reports 6.31% decrease in ownership of EW / Edwards Lifesciences Corporation

On April 23, 2026 - Granite Harbor Advisors, Inc. filed a 13F-HR form disclosing ownership of 4,517 shares of Edwards Lifesciences Corporation (MX:EW) valued at $361,721 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 22, 2026 disclosing 4,821 shares of Edwards Lifesciences Corporation. This represents a change in shares of -6.31% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-23 2026-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 4,517 -304 -6.31 362 -11.95 0.1579
2026-01-22 2025-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 4,821 97 2.05 411 11.72 0.1736
2025-10-22 2025-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 4,724 -24 -0.51 367 -1.08 0.1545
2025-07-30 2025-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 4,748 -241 -4.83 371 2.77 0.1744
2025-05-13 2025-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 4,989 462 10.21 362 7.76 0.1920
2025-01-23 2024-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 4,527 57 1.28 335 13.95 0.1854
2024-10-11 2024-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 4,470 463 11.55 295 -20.54 0.1707
2024-07-26 2024-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 4,007 185 4.84 370 1.37 0.2348
2024-04-30 2024-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 3,822 32 0.84 365 26.74 0.2490
2024-01-19 2023-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 3,790 -42 -1.10 289 8.68 0.2170
2023-11-17 2023-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 3,832 155 4.22 265 -23.41 0.2133
2023-11-17 2023-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 3,677 181 5.18 347 19.72 0.2695
2023-11-17 2023-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 3,496 -7 -0.20 289 10.73 0.2639
2023-11-17 2022-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 3,503 3,503 261 0.2662
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.